Content area

|
|

Cannabinoider til behandling af neuropatiske smerter

Forfattere
Lasse Østergaard Andersen, Thomas Peter Enggaard & Jette Højsted Tværfagligt Smertecenter, Rigshospitalet Ugeskr Læger 2018;180:V08170602
Reference: 
Ugeskr Læger 2018;180:V08170602
Sidetal: 
2-7
Cannabinoids for neuropathic pain management
Pharmacological treatment of neuropathic pain is associated with side effects and limited efficacy. Recently, the interest in cannabis-based medicine has led to legalisation of medical cannabis in some countries. The aim of this review is to evaluate the evidence of cannabinoids in neuropathic pain. Seventeen trials were identified; eight reported an analgesic efficacy of cannabis-based medicine, and the remaining trials showed no analgesic efficacy. Conclusions were limited by design of studies and short duration of treatment. Overall, the reduction in pain was minimal.

💬 0 Kommentarer

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Nicolas Storm | 19/05
3 kommentarer
af Sten Arne Oyre | 18/05
2 kommentarer
af Pedram Kazemi-Esfarjani | 18/05
2 kommentarer
af Helle Holst | 18/05
1 Kommentar
af Kirsten Bække Franck | 17/05
9 kommentarer
af Finn Østergård Bærentzen | 16/05
1 Kommentar
af Allan Carlé | 16/05
8 kommentarer
af Sven Felsby | 14/05
1 Kommentar
af Thorkil Poulsen | 13/05
5 kommentarer